rEVO Biologics Company Profile

13:06 EDT 27th April 2015 | BioPortfolio

rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recombinant therapies. Through its proprietary rPRO Technology platform -- a scalable, transgenic, and cost-effective method of protein production-- rEVO Biologics is bringing safe and reliable therapeutic proteins to address critical medical needs. The company’s lead product, ATryn® Antithrombin (Recombinant), is the first and only plasma-free antithrombin concentrate. ATryn received FDA approval in 2009. The company has a number of products in its pipeline and in clinical trials in the areas of hematology, oncology, genetic disorders and autoimmune disease, and is actively seeking additional indications for its lead product.


News Articles [387 Associated News Articles listed on BioPortfolio]

rEVO Biologics spearheading preeclampsia treatment

Closely held rEVO Biologics is enrolling patients in a Phase 3 clinical trial of its ATryn recombinant human antithrombin for the treatment of early-onset preeclampsia, with top-line data expected in ...

WuXi PharmaTech Making Good on Biologics Investments

With the end of 2014 almost here, WuXi PharmaTech sent a Christmas greeting that highlights the China CRO/CMO's accomplishments in biologics, including having built the largest biologics development t...

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

Qu Biologics to work with University of Rochester

Vancouver, BC – Qu Biologics Inc. reports it has initiated a research collaboration with the laboratory of Dr. Michael R. Elliott of the University of Rochester School of Medicine and Dentistry....

Biologics Are Revolutionizing Care for Some Diseases, But They Are Very Costly

(Washington Post) – Biologics are different from chemically derived drugs such as antibiotics: They are made from living organisms and require special handling in a controlled temperature while ...

New anorexia treatment in the works? Cambridge startup gets $28.3M to develop biologics that restore homeostasis

Biologics are typically used as therapeutics, but a Cambridge startup is using precise protein chemistry to move the field a little closer to the nutraceutical space. Pronutria‘s biologics are ...

AstraZeneca to Expand Frederick Biologics Mfg. Center

Increased production capacity to support maturing biologics pipeline

AstraZeneca to Expand its Maryland Biologics Manufacturing Centre

US$200+ million investment to support company's maturing biologics pipeline

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [78 Associated PubMed Articles listed on BioPortfolio]

When biologics should be used in systemic lupus erythematosus?

Recently, the use and evaluation of biologics increased in systemic lupus erythematosus (SLE). However, no international recommendation is available concerning the use of biologics with regards to the...

Patch Test Results in Psoriasis Patients on Biologics.

The objective of this study was to determine the prevalence of positive patch tests in patients with psoriasis receiving biologics and whether these results differ from those of patients with psoriasi...

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review.

Economic evaluations provide information to aid the optimal utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) are remarkably high, which makes these agents ...

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States.

Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.

How Should We Evaluate Outcomes for Use of Biologics in the Knee?

In recent years, the use of biologics for the primary treatment and augmentation of treatment in patients with knee pathology has increased substantially. Techniques and applications for biologic prep...

Clinical Trials [29 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs) ...

Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

Biologics are routinely used for the treatment of rheumatoid arthritis (RA). Adalimumab is a human monoclonal antibody that inhibit the Tumor Necrosis Factor alpha (TNF-alpha). Identificat...

Companies [199 Associated Companies listed on BioPortfolio]

rEVO Biologics

rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recom...

rEVO Biologics Inc.

rEVO Biologics Inc. (www.revobiologics.com) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address ...

rEVO Biologics, Inc.

rEVO Biologics, Inc. (www.revobiologics.com) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address ...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

More Information about "rEVO Biologics" on BioPortfolio

We have published hundreds of rEVO Biologics news stories on BioPortfolio along with dozens of rEVO Biologics Clinical Trials and PubMed Articles about rEVO Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of rEVO Biologics Companies in our database. You can also find out about relevant rEVO Biologics Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Blood
Latest News Clinical Trials Research Drugs Reports Corporate
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record